BrightInsight

We are excited to announce that BrightInsight has been named to Forbes prestigious ranking of America’s Best Startup Employers for 2024 for the second year in a row! 🏆 The annual list analyzes over 7 million data points to rank the top employers at high performing startup companies, and bases the list on growth, employer reputation, and employee satisfaction. Learn more here: https://lnkd.in/g2qb9--q Congrats to the entire #BrightInsight team! 🍾

It has been a breakout year for generative AI as we started to see how companies could use it to better meet consumer needs. This is an exciting time to be at #BrightInsight, a company that strives to transform patient care through #digitalhealth solutions — and it’s also a time for both discernment and proactive risk management as we develop products for patient and clinician usage that may be used in clinical decision support and disease management. Check out this new blog from Adam Samuels to learn more about BrightInsight’s principles for using artificial intelligence: https://lnkd.in/ezp2AhvZ

AI is everywhere, including healthcare. But how should it be regulated? And what challenges and opportunities does regulation bring? To gain some clarity on this important and ever-evolving topic, we sat down with Elisabethann Wright, a lawyer and regulatory policy expert who advises #BrightInsight — she’s a true expert on all things regulatory in healthcare technology. Check out this new blog to learn more: https://lnkd.in/gFRERn9g

In this episode of our Digital Health C-Suite Series, Amar Goel, CEO and Co-founder, Bito, talks about the AI and GenAI basics, the potential in healthcare and if #biopharma is actually ready to take advantage of the latest in AI technology. Check out the full interview here: https://lnkd.in/gSk43JZ3

Half a billion patients worldwide are living with cardiovascular disease. Digital can enhance their treatment and improve their quality of life, while driving value for #biopharma companies. Learn more in our white paper, Leveraging digital to drive value for your cardiovascular therapies: https://lnkd.in/g4gaJPay #cardiovasculardisease #digitalhealth #brightinsight

We are absolutely thrilled to announce that #BrightInsight recently concluded its audits towards the ISO 13485:2016, MDSAP EU MDR QMS compliance with ZERO OBSERVATIONS/FINDINGS!! 🎉 It was an intense 5 days of multi-phased audits by BrightInsight’s notified body. We want to extend a big THANK YOU to the extended team who supported the audits: Brian Goemans, Linda Goodstein, Joe Stearns, Alexandre Guerrini, Niloufar Mobarrez, Nilu Mishra II IIM - L II Miranda House, Sarah Machado, Vaibhav Sharma, Veeresh S., Shane Eum, Lucas Holt, Arvind Kumar, Marcus Muddell, Kyle Becker, Taeho Kim, Elena 🌼 A., Adam Samuels, Heather Gwynn, Paul E. DuCharme, Preeti B., Sarah Thompson, CPA, and Vanshaj Singhal! These successful audits reflect the robustness of BrightInsight’s Quality Management System and its ability to bring compliant products to various geographies across the globe. Bravo team! 👏

We are absolutely thrilled to announce that #BrightInsight recently concluded its audits towards the ISO 13485:2016, MDSAP EU MDR QMS compliance with ZERO OBSERVATIONS/FINDINGS!! 🎉 It was an intense 5 days of multi-phased audits by BrightInsight’s notified body. We want to extend a big THANK YOU to the extended team who supported the audits: Brian Goemans, Linda Goodstein, Joe Stearns, Alexandre Guerrini, Niloufar Mobarrez, Nilu Mishra II IIM - L II Miranda House, Sarah Machado, Vaibhav Sharma, Veeresh S., Shane Eum, Lucas Holt, Arvind Kumar, Marcus Muddell, Kyle Becker, Taeho Kim, Elena 🌼 A., Adam Samuels, Heather Gwynn, Paul E. DuCharme, Preeti B., Sarah Thompson, CPA, and Vanshaj Singhal! These successful audits reflect the robustness of BrightInsight’s Quality Management System and its ability to bring compliant products to various geographies across the globe. Bravo team! 👏

In this installment of the BrightInsight Digital Health C-Suite Series, we sat down with our own Ashish Agrawal, CTO, BrightInsight, to discuss how #BrightInsight is leveraging AI to enhance its Disease Management Solution, the top use cases for AI in #biopharma and how he's incorporating AI in his everyday life. Check out this full Digital Health C-Suite Series interview and others here: https://lnkd.in/gfcAYE9z

AI in healthcare continues to accelerate rapidly, with potential use cases being demonstrated across the healthcare sector including drug discovery, virtual clinical consultation, disease diagnosis, prognosis, medication management and health monitoring. Check out Kal Patel, M.D., MBA's new Nasdaq article to learn more how generative AI impacts the business of healthcare: https://lnkd.in/eg_pBHbT

In this interview, Kal Patel, M.D., MBA, CEO and Co-Founder at #BrightInsight, talks about how #biopharma can leverage AI to drive revenue and improve patient experiences on their therapies, and why top life science companies trust BrightInsight with their biggest brands in their biggest markets. Check out this full Digital Health C-Suite Series interview and others here: https://lnkd.in/g_2hrwCs